Novel Curcumin Derivative CNB-001 Mitigates Obesity-Associated Insulin Resistance

Type 2 diabetes is growing at epidemic proportions, and pharmacological interventions are being actively sought. This study examined the effect of a novel neuroprotective curcuminoid, CNB-001 [4-((1E)-2-(5-(4-hydroxy-3-methoxystyryl-)-1-phenyl-1H-pyrazoyl-3-yl)vinyl)-2-methoxy-phenol], on glucose in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Panzhinskiy, Evgeniy, Hua, Yinan, Lapchak, Paul A., Topchiy, Elena, Lehmann, Teresa E., Ren, Jun, Nair, Sreejayan
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Pharmacology and Experimental Therapeutics 2014
Assuntos:
Drug Discovery and Translational Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3989800/
https://ncbi.nlm.nih.gov/pubmed/24549372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.113.208728
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados